£246 M

ECEL.L Mkt cap, 31-Oct-2017

£204.8 M

Eurocell Revenue FY, 2016
Eurocell Revenue growth (FY, 2015 - FY, 2016), %16%
Eurocell Gross profit (FY, 2016)106.6 M
Eurocell Gross profit margin (FY, 2016), %52%
Eurocell Net income (FY, 2016)19.6 M
Eurocell EBITDA (FY, 2016)30.9 M
Eurocell EBIT (FY, 2016)24.5 M
Eurocell Cash, 31-Dec-20165.6 M
Eurocell EV240.5 M

Eurocell Financials

Eurocell Income Statement

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016

Revenue

55.1 m173.1 m175.9 m204.8 m

Revenue growth, %

2%16%

Cost of goods sold

28.5 m89.5 m84.9 m98.3 m

Gross profit

26.6 m83.6 m91 m106.6 m

Gross profit Margin, %

48%48%52%52%

Operating expense total

25.3 m63.3 m70 m82.1 m

EBITDA

3.1 m25 m26.6 m30.9 m

EBITDA margin, %

6%14%15%15%

EBIT

1.4 m20.3 m21 m24.5 m

EBIT margin, %

2%12%12%12%

Pre tax profit

(131 k)16.7 m19.7 m23.8 m

Income tax expense

(284 k)(5 m)(4.2 m)(4.2 m)

Net Income

(415 k)11.8 m15.5 m19.6 m

Eurocell Balance Sheet

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.3 m2.8 m1.2 m5.6 m

Accounts Receivable

20.8 m18.9 m21.5 m25.3 m

Inventories

15.2 m14.7 m18.1 m17.4 m

Current Assets

39.4 m37.9 m44.2 m51.1 m

PP&E

28 m25.7 m27.6 m29.3 m

Goodwill

14.5 m19.7 m

Total Assets

81.9 m77.7 m86.3 m100.1 m

Accounts Payable

15.1 m13.5 m19.4 m18.4 m

Current Liabilities

44.2 m38.2 m29.7 m32 m

Non-Current Liabilities

38.1 m28 m30.1 m30 m

Total Debt

12.9 m1.3 m42 k

Total Liabilities

82.2 m66.2 m59.8 m62 m

Additional Paid-in Capital

2 k52 k100 k100 k

Retained Earnings

(415 k)11.8 m12.8 m11.6 m

Total Equity

(314 k)11.5 m26.6 m38.1 m

Debt to Equity Ratio

1.1 x0 x0 x

Debt to Assets Ratio

0.2 x0 x0 x

Financial Leverage

-260.9 x6.7 x3.3 x2.6 x

Eurocell Cash Flow

Annual

GBPFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(415 k)11.8 m15.5 m19.6 m

Cash From Operating Activities

2.4 m19.8 m19.4 m28.4 m

Dividends Paid

2.7 m8 m

Cash From Financing Activities

46 m(10 m)(14.4 m)(9.2 m)

Net Change in Cash

3.3 m(557 k)(2.9 m)5.7 m

Income Taxes Paid

(4.2 m)(4.2 m)

Eurocell Ratios

GBPY, 2016

EV/EBITDA

7.8 x

EV/EBIT

9.8 x

EV/CFO

8.5 x

Financial Leverage

2.6 x
Report incorrect company information